DSpace Repository

Herbal Product in the Treatment of Covid-19

Show simple item record

dc.contributor.author Das, Anamika
dc.date.accessioned 2022-10-27T03:12:20Z
dc.date.available 2022-10-27T03:12:20Z
dc.date.issued 2021-12
dc.identifier.uri http://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/8800
dc.description.abstract : SARS-CoV-2, also known as COVID19, has infected individuals all over the world since its breakout in late December 2019. Coronavirus disease 2019 (COVID-19), caused by extreme acute respiratory coronavirus-2 (SARS-CoV-2), is a highly contagious disease that has already infected roughly a million individuals and killed a large number of people throughout the world. COVID-19 has a wide clinical spectrum, ranging from mild sickness with vague signs and symptoms of acute respiratory disease to severe respiratory pneumonia and septic shock. It can be transmitted from human to human by contact, air, water, utensils, and fomite. Self-isolation, relaxation, and water, including the use of NSAIDs solely in cases of severe fever, are now recommended for the self-management of SARS-Cov-2 sickness (COVID-19). In the absence of curative pharmaceuticals, various measures like herbal products are being investigated to slow the pandemic's wave. Acute respiratory infections have traditionally been treated with natural products and herbal medications. To analyze the advantages and dangers of certain herbal medications usually used to cure "respiratory infections" as adjuvant therapy in the current COVID-19 pandemic. This review focuses on several herbal products that have been shown to have an inhibiting impact on human coronavirus symptoms, as well as the herbal treatments that have recently been employed for COVID-19. Plants were chosen mostly from the WHO and EMA's list of species, but additional herbal treatments were also evaluated due to their extensive usage in respiratory disorders. According to this study herbal medicines like Withania somnifera, Ocimum gratissimum, Cinchona officinalis, Curcuma longa, Althaea officinalis, Cymbopogon citratus, Foeniculum vulgare, Thymus vulgaris, Nigella sativa, and Silybum marianum should be regarded as promising candidates because of their reasonable safety margins and emerging evidence for efficacy in the treatment of mild common flu and mild respiratory conditions. Although medicinal plants have the ability to cure COVID, there is a possibility that these therapies may have unfavorable side effects and will have a negative impact on lactating mothers. As a result, further research is needed to prove their usefulness and uncover compounds with potential therapeutic uses. en_US
dc.language.iso en_US en_US
dc.publisher Daffodil International University en_US
dc.subject COVID-19 (Disease) en_US
dc.subject Diseases--Outbreaks en_US
dc.subject Herbals en_US
dc.subject Medicinal plants en_US
dc.title Herbal Product in the Treatment of Covid-19 en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account

Statistics